Advertisement Mylan revenues up 12% in Q1 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Mylan revenues up 12% in Q1

Mylan has posted total revenues of $1.45bn for the first quarter ended 31 March 2011, an increase of 12%, compared to $1.29bn for the same period in 2010.

The company has reported net earnings of $104.55m, compared to $94.27m for the same period prior year.

For the first quarter of 2011, Mylan‘s earnings from operations was $211.68m, as compared to $198.51m for the same period last year.

Gross profit for the quarter ended 31 March 2011 was $590.9m, compared to $516.3m for the same period in 2010.

Mylan chairman and CEO Robert Coury said they are reaffirming their 2011 adjusted diluted EPS guidance of $1.90 to $2.10 per share, and their 2013 growth targets.